Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)

:2395

2395

Shin Nippon Biomedical Laboratories, Ltd.

RESEARCH TOOLSreports

Shin Nippon Biomedical Laboratories, Ltd. (2395) Ratios

Compare

2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Ratios

JP:2395's free cash flow for Q1 2025 was ¥0.47. For the 2025 fiscal year, JP:2395's free cash flow was decreased by ¥ and operating cash flow was ¥0.06. See a summary of the company’s cash flow.

Ratios	TTM	Mar 25	Mar 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	1.08	1.13	1.31	1.14	1.21
Quick Ratio	0.63	0.69	0.78	0.79	0.88
Cash Ratio	0.44	0.41	0.44	0.50	0.50
Solvency Ratio	0.12	0.14	0.18	0.25	0.42
Operating Cash Flow Ratio	0.00	0.24	0.09	0.19	0.45
Short-Term Operating Cash Flow Coverage	0.00	0.59	0.27	0.45	2.02
Net Current Asset Value	¥ -22.05B	¥ -19.39B	¥ -11.30B	¥ -6.98B	¥ -3.46B
Leverage Ratios
Debt-to-Assets Ratio	0.37	0.37	0.34	0.33	0.23
Debt-to-Equity Ratio	0.79	0.86	0.77	0.72	0.47
Debt-to-Capital Ratio	0.44	0.46	0.43	0.42	0.32
Long-Term Debt-to-Capital Ratio	0.30	0.36	0.35	0.27	0.23
Financial Leverage Ratio	2.14	2.31	2.24	2.18	2.01
Debt Service Coverage Ratio	0.38	0.63	0.94	0.86	2.76
Interest Coverage Ratio	8.18	14.72	29.99	41.94	33.13
Debt to Market Cap	0.66	0.57	0.42	0.16	0.12
Interest Debt Per Share	1.00K	836.12	632.36	453.65	222.54
Net Debt to EBITDA	3.28	2.56	1.77	0.87	0.26
Profitability Margins
Gross Profit Margin	50.35%	51.12%	54.00%	52.00%	54.58%
EBIT Margin	15.16%	19.18%	26.89%	31.42%	46.82%
EBITDA Margin	25.34%	27.23%	33.95%	37.80%	53.45%
Operating Profit Margin	6.75%	9.21%	15.74%	20.90%	23.64%
Pretax Profit Margin	15.09%	18.55%	26.37%	30.93%	46.11%
Net Profit Margin	12.72%	15.19%	20.91%	24.15%	40.16%
Continuous Operations Profit Margin	12.50%	15.01%	20.86%	24.12%	40.38%
Net Income Per EBT	84.29%	81.90%	79.31%	78.10%	87.10%
EBT Per EBIT	223.41%	201.43%	167.56%	147.94%	195.04%
Return on Assets (ROA)	3.53%	5.33%	7.25%	10.59%	18.13%
Return on Equity (ROE)	9.60%	12.31%	16.21%	23.12%	36.44%
Return on Capital Employed (ROCE)	2.71%	4.73%	7.89%	14.48%	16.18%
Return on Invested Capital (ROIC)	1.81%	3.22%	5.44%	9.06%	12.72%
Return on Tangible Assets	3.59%	5.45%	7.46%	10.91%	18.23%
Earnings Yield	6.37%	8.27%	8.84%	5.29%	10.09%
Efficiency Ratios
Receivables Turnover	6.33	4.98	4.62	5.34	5.07
Payables Turnover	20.53	34.37	26.42	28.69	124.84
Inventory Turnover	0.99	1.26	0.98	1.64	1.85
Fixed Asset Turnover	0.87	0.93	1.00	1.33	1.35
Asset Turnover	0.28	0.35	0.35	0.44	0.45
Working Capital Turnover Ratio	10.89	5.92	5.21	8.88	6.31
Cash Conversion Cycle	409.01	353.42	436.31	277.69	266.43
Days of Sales Outstanding	57.62	73.33	78.97	68.29	71.96
Days of Inventory Outstanding	369.18	290.70	371.15	222.12	197.39
Days of Payables Outstanding	17.78	10.62	13.81	12.72	2.92
Operating Cycle	426.79	364.04	450.13	290.41	269.35
Cash Flow Ratios
Operating Cash Flow Per Share	0.00	168.99	50.60	96.18	142.99
Free Cash Flow Per Share	0.00	-91.72	-156.10	-22.86	104.21
CapEx Per Share	0.00	260.70	206.70	119.04	38.77
Free Cash Flow to Operating Cash Flow	0.00	-0.54	-3.08	-0.24	0.73
Dividend Paid and CapEx Coverage Ratio	0.00	0.54	0.20	0.54	2.44
Capital Expenditure Coverage Ratio	0.00	0.65	0.24	0.81	3.69
Operating Cash Flow Coverage Ratio	0.00	0.20	0.08	0.21	0.65
Operating Cash Flow to Sales Ratio	0.00	0.22	0.08	0.16	0.34
Free Cash Flow Yield	0.00%	-6.41%	-10.39%	-0.83%	6.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	15.69	12.10	11.31	18.89	9.91
Price-to-Sales (P/S) Ratio	2.00	1.84	2.37	4.56	3.98
Price-to-Book (P/B) Ratio	1.18	1.49	1.83	4.37	3.61
Price-to-Free Cash Flow (P/FCF) Ratio	0.00	-15.60	-9.63	-120.30	16.27
Price-to-Operating Cash Flow Ratio	0.00	8.47	29.70	28.59	11.86
Price-to-Earnings Growth (PEG) Ratio	-1.10	-1.10	-1.30	-1.26	0.10
Price-to-Fair Value	1.18	1.49	1.83	4.37	3.61
Enterprise Value Multiple	11.16	9.31	8.74	12.94	7.71
Enterprise Value	88.73B	82.15B	78.48B	122.71B	73.12B
EV to EBITDA	11.16	9.31	8.74	12.94	7.71
EV to Sales	2.83	2.53	2.97	4.89	4.12
EV to Free Cash Flow	0.00	-21.51	-12.08	-128.94	16.85
EV to Operating Cash Flow	0.00	11.68	37.25	30.65	12.28
Tangible Book Value Per Share	1.23K	912.33	768.69	592.34	468.65
Shareholders’ Equity Per Share	1.27K	961.35	819.45	629.62	469.86
Tax and Other Ratios
Effective Tax Rate	0.17	0.19	0.21	0.22	0.12
Revenue Per Share	753.61	778.58	635.36	602.70	426.32
Net Income Per Share	95.84	118.29	132.86	145.57	171.21
Tax Burden	0.84	0.82	0.79	0.78	0.87
Interest Burden	1.00	0.97	0.98	0.98	0.98
Research & Development to Revenue	0.10	0.07	0.07	0.03	0.02
SG&A to Revenue	0.01	0.01	0.07	0.02	0.02
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.00	1.43	0.38	0.52	0.84

Currency in JPY